Brucke Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.05M Buy
1,768
+571
+48% +$674K 0.86% 21
2026
Q2
$1.44M Sell
1,197
-21
-2% -$21.5K 0.64% 31
2026
Q1
$1.12M Buy
1,218
+107
+10% +$108K 0.57% 36
2025
Q4
$1.19M Sell
1,111
-29
-3% -$27.7K 0.65% 32
2025
Q3
$984K Buy
1,140
+53
+5% +$39.4K 0.58% 33
2025
Q2
$848K Sell
1,087
-19
-2% -$14.8K 0.59% 35
2025
Q1
$995K Sell
1,106
-11
-1% -$9.15K 0.86% 25
2024
Q4
$906K Buy
+1,117
New +$925K 0.78% 30

Other funds holding LLY

Brucke Financial's LLY Position: Q3 2026 in Review

Brucke Financial increased its Eli Lilly (LLY) stake by 48% in Q3 2026, buying an estimated $674K and bringing the position to 1,768 shares worth $2.05M. The position accounts for 0.86% of the portfolio, ranked #21.

Brucke Financial first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 2,089 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Brucke Financial held 1,768 shares of Eli Lilly worth $2.05M as of Q3 2026.
  • Brucke Financial bought 571 Eli Lilly shares in Q3 2026, an estimated $674K.
  • Eli Lilly made up 0.86% of Brucke Financial's portfolio in Q3 2026, its #21 holding.
  • Brucke Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 2,089 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Brucke Financial's 13F filing for Q3 2026, filed 23 Oct 2026.